Chemotherapy-induced, age-related changes in antischistosome antibody responses.
about
A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and BrazilEpidemiological Interactions between Urogenital and Intestinal Human Schistosomiasis in the Context of Praziquantel Treatment across Three West African CountriesIncreases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.Acquired immune heterogeneity and its sources in human helminth infection.Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmesGroup 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment.Schistosomiasis vaccines.Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection.Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya.Parasite glycans and antibody-mediated immune responses in Schistosoma infection.New Allergens of Relevance in Tropical Regions: The Impact of Ascaris lumbricoides Infections
P2860
Q28478552-6D36CD15-5AA6-40CF-941A-A66A7B9E95B0Q28550322-D311293C-715D-4B83-8694-CDAD2690A144Q33965354-16528C95-8302-438C-87FF-78270361CA67Q34256750-B1639811-DEBD-4BA6-B39D-C3DE629DA354Q34495730-683E02CF-3098-4936-8BDA-B67E02181724Q34629346-6858E104-2C35-415B-954B-1BA1F99BDBD9Q35208931-82387954-33A7-4EEA-A45E-293CFCDC13E2Q35594085-B0DE7F42-7456-4589-8173-9A342050B417Q36158825-558928F6-DE8F-49C1-959B-604B68C4A81CQ36942712-3B2D6B3E-3D83-4C5C-B1CA-F55829AF603AQ37680704-6A52C6F8-5B0D-422D-A0C3-56F96FEAF535Q37994231-4E8378D2-8FE0-46B4-AE85-4B20A4435F4EQ38071151-C6F6459B-613D-4A74-B3A6-688C0C5492E2
P2860
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@en
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@nl
type
label
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@en
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@nl
prefLabel
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@en
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@nl
P2093
P2860
P1433
P1476
Chemotherapy-induced, age-related changes in antischistosome antibody responses.
@en
P2093
Mark E J Woolhouse
Patricia D Ndhlovu
Takafira Mduluza
P2860
P356
10.1046/J.1365-3024.2003.00610.X
P577
2003-02-01T00:00:00Z